About
Learn about how Novartis is organized and our strategy, vision and mission. Meet our people and read about our commitments to diversity, equity and inclusion. Explore our history which goes back more than 250 years.
Patients and Caregivers
Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.
Healthcare Professionals
Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.
Research & Development
Discover how Novartis turns breakthrough science into transformative, high-value treatments.
Environmental, Social and Governance
Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.
Investors
Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.
News
Information for journalists including media releases, statements, stories, multimedia resources and more.
Careers
Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.
Clinical Trials
Find recruiting clinical trials and learn more about how to participate or work with Novartis on clinical studies. Read about our clinical trials transparency initiatives.
Partnering
Learn about our approach to partnering which combines capabilities, collaboration and culture.
Supplier Portal
Practical information and resources for suppliers around the world.
Report side effects
Let us know about any unwanted medical occurrences.
Contacts
Get in touch.
Home
Welcome to Novartis where we are reimagining medicine to improve and extend people’s lives.
Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Novartis announced the company’s financial results for the second quarter and first half of 2023.
Novartis announced the company’s financial results for the first quarter of 2023.
Novartis announces the company’s fourth quarter and 2022 full year financial results.
Over 1 billion people volunteer worldwide, sharing their skills and experience, providing support within their communities, and offering emergency assistance to those in need. On International Volunteer Day (December 5), we join forces with the UN to recognize the tireless work of all volunteers and the contributions that they make.
Through the Avoidable Blindness Program, Novartis is working with partners to strengthen eye health in sub-Saharan Africa.
Developing treatments for blood cancers and serious blood disorders is important, but it is only part of the equation. We also need to help ensure those who may need our therapies can get them.
Novartis announced the company’s financial results for the second quarter and first half of 2022.
